Himalaya: Listen. Learn. Grow.

4.8K Ratings
Open In App
title

AIMedicine's podcast

Dr. Emma Nichols

0
Followers
0
Plays
AIMedicine's podcast

AIMedicine's podcast

Dr. Emma Nichols

0
Followers
0
Plays
OVERVIEWEPISODESYOU MAY ALSO LIKE

Details

About Us

Veteran medical writer Dr. Emma Nichols interviews company founders and researchers about medically related applications of artificial intelligence.

Latest Episodes

000 - Introductory episode

Episode 000. What this podcast is about, a little bit about Dr. Emma Nichols' background, and how she hopes this podcast will provide value. If you are involved in the AI and medicine space and would like to be interviewed for this podcast, please email info@scimedly.com. The first episode of AI in medicine is coming out on Wednesday January 4th, 2018. I will be talking with Dr. Alex Zhavoronkov who is the is the CEO of InSilico Medicine, Inc a company utilizing big data analysis for aging research. https://itunes.apple.com/us/podcast/aimedicines-podcast/id1325232000?mt=2 Please subscribe!

3 MIN2017 DEC 27
Comments
000 - Introductory episode

Season 1 - 001 - Dr. Alex Zhavoronkov founder of Insilico Medicine

Alex Zhavoronkov is Founder & Chief Executive Officer of Insilico Medicine (INSILICO.COM). In this episode Dr. Nichols asks him about how his company is using AI in drug discovery and also is trying to understand the effects of aging at the tissue and systemic level. Dr. Zhavoronkov also talks about his book about AI that he wrote in 2011 and how it fares in terms of predicting the current state of AI in 2017/2018. From a technology standpoint, some techniques have come to fruition, and some are obsolete, he says. But there have also been many technological shifts, such as blockchain technology, that he did not expect. The burden of aging on healthcare has increased as described in his book. Now his company and others are trying to solve the aging problem. He talks about how In Silico is partnering with a company founded by successful entrepreneurs Jim Mellon, Gregory Bailey, and Declan Doogan to bring about the development of new therapeutic molecules. He also talks about a partner...

32 MIN2018 JAN 3
Comments
Season 1 - 001 - Dr. Alex Zhavoronkov founder of Insilico Medicine

Season 1 - 002 - Dr. Mark Michalski Director of the BWH/MGH Center for Clinical Data Science

Dr. Mark Michalski, Director of the BWH/MGH Center for Clinical Data Science talks about what they do. Use of machine learning to interpret slides, identify signals in data. About 70% of the applications are focused on diagnostics, and the remainder focus on operations, population health, and identifying new drugs. They do research and translate that so it can be applied in clinical practice. They have strategic partnerships with Nvidia, GE, and several others in academics and in industry. Most exciting projects? Machine learning model for stenosis of the back; using machine learning to make MRIs go much faster; speeding up hospital operations. He was a radiologist, so how did he become interested in AI/machine learning? What will be the ramifications of AI? How will docs handle improved technology? Will it add to their workload? What do you predict for the future? Will AI take jobs?

18 MIN2018 JAN 10
Comments
Season 1 - 002 - Dr. Mark Michalski Director of the BWH/MGH Center for Clinical Data Science

Season 1 - 003 - ThinkGenetic - harnessing the power of data collection in rare genetic diseases

The founders of ThinkGenetic describe how the founder's genetic condition, cutis laxis, prompted them to start thinkgenetic.com. They used the power of data collection and AI/machine learning to create a symptom matcher to help diagnose rare genetic diseases. Interviewees: Dave Jacob, CEO and Co-Founder, ThinkGenetic Dawn Jacob Laney, MS, CGC, CCRC, Co-Founder, ThinkGenetic Ruth O'Keefe, Director of Marketing, ThinkGeneti AI Medicine news – aimedicinenews.com Precision Medicine World conference, Silicon Valley Jan 22-24. http://www.pmwcintl.com/2018sv/program/

35 MIN2018 JAN 17
Comments
Season 1 - 003 - ThinkGenetic - harnessing the power of data collection in rare genetic diseases

Season 1 - 004 - AI in optical biopsy for GI applications

AI in optical biopsy for GI applications AI4GI CEO Dr. Michael Byrne talks about optical biopsy using deep learning techniques. They built their startup in a very different way: they tried engaging the top key opinion leaders in GI and also AI, such as one of the founders of deep learning, Dr. Yoshua Bengio, from the outset. They built the team “very strategically” he says. Currently, there are 20 million screening colonoscopies a year in the US alone. Each time a polyp is removed, it has to be sent to a lab, and it delays giving an answer to the patient for maybe a week or two. The level of performance of the AI4GI system is about 95%, which exceeds that of the best human attempts for diagnosing cancerous vs. non-cancerous polyps. Plus, it’s essentially in real time, which means no anxious waiting for a couple of weeks while the biopsy results come back. Check out AImedicinenews.com the website for this podcast Also, check out NewFDAapprovals.com, Emma's daily podcast talking ab...

22 MIN2018 JAN 24
Comments
Season 1 - 004 - AI in optical biopsy for GI applications

Season 1 - 005 – AI in rare diseases - Healx CEO Tim Guilliams

Dr. Emma Nichols interviews Dr. Tim Guilliams, co-founder of Healx.io and he explains how they reduce the cost of identifying effective drugs for rare diseases, which affect 350 million individuals worldwide, with 95% having no effective treatment. They start with approved drugs and nutraceuticals and also look at combinations of drugs using artificial intelligence/deep learning. The company works closely with organizations and patient communities to help move their findings forward. So far, he says, every project has been successful. They have identified candidates for Fragile X syndrome and CD5 syndrome (?), which will be tested in humans soon. There’s also a triplet combination that has shown very high efficacy in severe diarrhea. “There’s never been a more exciting time for drug discovery,” Dr. Guilliams says. Just a quick note, I say in the recording that the website is healx.com, but it’s actually healx.io. Please check out the website for this podcast which is aimedicine...

18 MIN2018 JAN 31
Comments
Season 1 - 005 – AI in rare diseases - Healx CEO Tim Guilliams

Season 1 - 006 - Arterys' cloud based imaging using AI

In this episode I talk with Carla Leibowitz, who is the head of Strategy and Marketing at Arterys. She describes the technology they have created at Arterys: AI-based cardiology, lung, and liver applications. Arterys received 510(k) clearance from the U.S. Food and Drug Administration for its software in November 2016. This clearance allowed the Arterys product to be used in clinical settings for the quantification of cardiac flow, which includes 4D flow and 2D Phase Contrast workflows, and cardiac function measurements. She discusses how clinicians can interact with Arterys and onboard the software. She also points out that AI isn't going to be taking clinician jobs. Rather, they are trying to give them superpowers! Check out this podcast's website AIMedicineNews.com Pease check out Emma's other podcast, New FDA Approvals. This shorter podcast comes out 5 days a week, Monday through Friday, and covers the real time happenings coming out of the FDA. It is meant to inform healthcare ...

11 MIN2018 FEB 7
Comments
Season 1 - 006 - Arterys' cloud based imaging using AI

Season 1 - 007 - WuxiNextCode global genomics big data platform

Today, I talk with Hannes Smárason, the CEO and cofounder of WuXiNextCODE, and Dr. Edward Farmer, the company’s Executive VP, Communications & New Ventures. They talk about why their company is laser focused on the China market and their predictions for the future directions of their global platform for genomics big data.

13 MIN2018 FEB 15
Comments
Season 1 - 007 - WuxiNextCode global genomics big data platform

Season 1 - 008 - IQVIA, Data, and Healthcare

Austin Caudle, Associate Director, R&D Solutions at IQVIA, describes how the company uses data to help clients develop clinical trial protocols and identify hard-to-find patients for clinical trials. “A lot of people don’t really realize the scale and complexity of working with data,” he says. “We spent the last 4 years an advanced healthcare data cloud resulting in 300 technology patents and patent applications.” Find out more. Please visit this podcast’s website at http://aimedicinenews.com Contact info@nascentmc.com for your medical writing needs.

15 MIN2018 FEB 21
Comments
Season 1 - 008 - IQVIA, Data, and Healthcare

Season 1 - 009 - Curemetrix's CEO Kevin Harris talks about AI-based mammography

Kevin Harris, CEO of Curemetrix, describes how researchers at his company took space imaging technology and applied it to the medical field, specifically mammography. “If we get this right, it’s breast cancer… we can really have an impact,” he says. They may be able to find cancer earlier; they were able to look 6 years earlier and find anomalies that were missed by doctors and eventually grew into cancers. Harris says the technology may really help improve outcomes for patients. They are in the process of getting FDA approval for their product CMAssist. Doctors can currently test it out for investigational uses prospectively and can also provide retrospective data for analysis. Please subscribe, rate and review if you like this podcast. Thank you! The podcast website is http://aimedicinenews.com

16 MIN2018 FEB 28
Comments
Season 1 - 009 - Curemetrix's CEO Kevin Harris talks about AI-based mammography

Latest Episodes

000 - Introductory episode

Episode 000. What this podcast is about, a little bit about Dr. Emma Nichols' background, and how she hopes this podcast will provide value. If you are involved in the AI and medicine space and would like to be interviewed for this podcast, please email info@scimedly.com. The first episode of AI in medicine is coming out on Wednesday January 4th, 2018. I will be talking with Dr. Alex Zhavoronkov who is the is the CEO of InSilico Medicine, Inc a company utilizing big data analysis for aging research. https://itunes.apple.com/us/podcast/aimedicines-podcast/id1325232000?mt=2 Please subscribe!

3 MIN2017 DEC 27
Comments
000 - Introductory episode

Season 1 - 001 - Dr. Alex Zhavoronkov founder of Insilico Medicine

Alex Zhavoronkov is Founder & Chief Executive Officer of Insilico Medicine (INSILICO.COM). In this episode Dr. Nichols asks him about how his company is using AI in drug discovery and also is trying to understand the effects of aging at the tissue and systemic level. Dr. Zhavoronkov also talks about his book about AI that he wrote in 2011 and how it fares in terms of predicting the current state of AI in 2017/2018. From a technology standpoint, some techniques have come to fruition, and some are obsolete, he says. But there have also been many technological shifts, such as blockchain technology, that he did not expect. The burden of aging on healthcare has increased as described in his book. Now his company and others are trying to solve the aging problem. He talks about how In Silico is partnering with a company founded by successful entrepreneurs Jim Mellon, Gregory Bailey, and Declan Doogan to bring about the development of new therapeutic molecules. He also talks about a partner...

32 MIN2018 JAN 3
Comments
Season 1 - 001 - Dr. Alex Zhavoronkov founder of Insilico Medicine

Season 1 - 002 - Dr. Mark Michalski Director of the BWH/MGH Center for Clinical Data Science

Dr. Mark Michalski, Director of the BWH/MGH Center for Clinical Data Science talks about what they do. Use of machine learning to interpret slides, identify signals in data. About 70% of the applications are focused on diagnostics, and the remainder focus on operations, population health, and identifying new drugs. They do research and translate that so it can be applied in clinical practice. They have strategic partnerships with Nvidia, GE, and several others in academics and in industry. Most exciting projects? Machine learning model for stenosis of the back; using machine learning to make MRIs go much faster; speeding up hospital operations. He was a radiologist, so how did he become interested in AI/machine learning? What will be the ramifications of AI? How will docs handle improved technology? Will it add to their workload? What do you predict for the future? Will AI take jobs?

18 MIN2018 JAN 10
Comments
Season 1 - 002 - Dr. Mark Michalski Director of the BWH/MGH Center for Clinical Data Science

Season 1 - 003 - ThinkGenetic - harnessing the power of data collection in rare genetic diseases

The founders of ThinkGenetic describe how the founder's genetic condition, cutis laxis, prompted them to start thinkgenetic.com. They used the power of data collection and AI/machine learning to create a symptom matcher to help diagnose rare genetic diseases. Interviewees: Dave Jacob, CEO and Co-Founder, ThinkGenetic Dawn Jacob Laney, MS, CGC, CCRC, Co-Founder, ThinkGenetic Ruth O'Keefe, Director of Marketing, ThinkGeneti AI Medicine news – aimedicinenews.com Precision Medicine World conference, Silicon Valley Jan 22-24. http://www.pmwcintl.com/2018sv/program/

35 MIN2018 JAN 17
Comments
Season 1 - 003 - ThinkGenetic - harnessing the power of data collection in rare genetic diseases

Season 1 - 004 - AI in optical biopsy for GI applications

AI in optical biopsy for GI applications AI4GI CEO Dr. Michael Byrne talks about optical biopsy using deep learning techniques. They built their startup in a very different way: they tried engaging the top key opinion leaders in GI and also AI, such as one of the founders of deep learning, Dr. Yoshua Bengio, from the outset. They built the team “very strategically” he says. Currently, there are 20 million screening colonoscopies a year in the US alone. Each time a polyp is removed, it has to be sent to a lab, and it delays giving an answer to the patient for maybe a week or two. The level of performance of the AI4GI system is about 95%, which exceeds that of the best human attempts for diagnosing cancerous vs. non-cancerous polyps. Plus, it’s essentially in real time, which means no anxious waiting for a couple of weeks while the biopsy results come back. Check out AImedicinenews.com the website for this podcast Also, check out NewFDAapprovals.com, Emma's daily podcast talking ab...

22 MIN2018 JAN 24
Comments
Season 1 - 004 - AI in optical biopsy for GI applications

Season 1 - 005 – AI in rare diseases - Healx CEO Tim Guilliams

Dr. Emma Nichols interviews Dr. Tim Guilliams, co-founder of Healx.io and he explains how they reduce the cost of identifying effective drugs for rare diseases, which affect 350 million individuals worldwide, with 95% having no effective treatment. They start with approved drugs and nutraceuticals and also look at combinations of drugs using artificial intelligence/deep learning. The company works closely with organizations and patient communities to help move their findings forward. So far, he says, every project has been successful. They have identified candidates for Fragile X syndrome and CD5 syndrome (?), which will be tested in humans soon. There’s also a triplet combination that has shown very high efficacy in severe diarrhea. “There’s never been a more exciting time for drug discovery,” Dr. Guilliams says. Just a quick note, I say in the recording that the website is healx.com, but it’s actually healx.io. Please check out the website for this podcast which is aimedicine...

18 MIN2018 JAN 31
Comments
Season 1 - 005 – AI in rare diseases - Healx CEO Tim Guilliams

Season 1 - 006 - Arterys' cloud based imaging using AI

In this episode I talk with Carla Leibowitz, who is the head of Strategy and Marketing at Arterys. She describes the technology they have created at Arterys: AI-based cardiology, lung, and liver applications. Arterys received 510(k) clearance from the U.S. Food and Drug Administration for its software in November 2016. This clearance allowed the Arterys product to be used in clinical settings for the quantification of cardiac flow, which includes 4D flow and 2D Phase Contrast workflows, and cardiac function measurements. She discusses how clinicians can interact with Arterys and onboard the software. She also points out that AI isn't going to be taking clinician jobs. Rather, they are trying to give them superpowers! Check out this podcast's website AIMedicineNews.com Pease check out Emma's other podcast, New FDA Approvals. This shorter podcast comes out 5 days a week, Monday through Friday, and covers the real time happenings coming out of the FDA. It is meant to inform healthcare ...

11 MIN2018 FEB 7
Comments
Season 1 - 006 - Arterys' cloud based imaging using AI

Season 1 - 007 - WuxiNextCode global genomics big data platform

Today, I talk with Hannes Smárason, the CEO and cofounder of WuXiNextCODE, and Dr. Edward Farmer, the company’s Executive VP, Communications & New Ventures. They talk about why their company is laser focused on the China market and their predictions for the future directions of their global platform for genomics big data.

13 MIN2018 FEB 15
Comments
Season 1 - 007 - WuxiNextCode global genomics big data platform

Season 1 - 008 - IQVIA, Data, and Healthcare

Austin Caudle, Associate Director, R&D Solutions at IQVIA, describes how the company uses data to help clients develop clinical trial protocols and identify hard-to-find patients for clinical trials. “A lot of people don’t really realize the scale and complexity of working with data,” he says. “We spent the last 4 years an advanced healthcare data cloud resulting in 300 technology patents and patent applications.” Find out more. Please visit this podcast’s website at http://aimedicinenews.com Contact info@nascentmc.com for your medical writing needs.

15 MIN2018 FEB 21
Comments
Season 1 - 008 - IQVIA, Data, and Healthcare

Season 1 - 009 - Curemetrix's CEO Kevin Harris talks about AI-based mammography

Kevin Harris, CEO of Curemetrix, describes how researchers at his company took space imaging technology and applied it to the medical field, specifically mammography. “If we get this right, it’s breast cancer… we can really have an impact,” he says. They may be able to find cancer earlier; they were able to look 6 years earlier and find anomalies that were missed by doctors and eventually grew into cancers. Harris says the technology may really help improve outcomes for patients. They are in the process of getting FDA approval for their product CMAssist. Doctors can currently test it out for investigational uses prospectively and can also provide retrospective data for analysis. Please subscribe, rate and review if you like this podcast. Thank you! The podcast website is http://aimedicinenews.com

16 MIN2018 FEB 28
Comments
Season 1 - 009 - Curemetrix's CEO Kevin Harris talks about AI-based mammography
hmly
Welcome to Himalaya LearningDozens of podcourses featuring over 100 experts are waiting for you.